Literature DB >> 458483

Benign recurrent vertigo.

R Slater.   

Abstract

Patients with recurrent vertigo in the absence of cochlear signs remain a diagnostic problem. The absence of a standard system of nomenclature further hampers the understanding of these disorders. The term benign recurrent vertigo is suggested as a useful term to characterise many of these patients. The disorder shares some of the features of migraine, and seems likely to have a similar vasospastic aetiology.

Entities:  

Mesh:

Year:  1979        PMID: 458483      PMCID: PMC490208          DOI: 10.1136/jnnp.42.4.363

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  PAROXYSMAL POSITIONAL NYSTAGMUS; AN ELECTRONYSTAGMOGRAPHIC AND CLINICAL STUDY.

Authors:  J STAHLE; J TERINS
Journal:  Ann Otol Rhinol Laryngol       Date:  1965-03       Impact factor: 1.547

2.  Vestibulocerebellar ataxia. A newly defined hereditary syndrome with periodic manifestations.

Authors:  T W FARMER; V M MUSTIAN
Journal:  Arch Neurol       Date:  1963-05

3.  "Epidemic vertigo"-"vestibular neuronitis". A clinical study.

Authors:  M S HARRISON
Journal:  Brain       Date:  1962-09       Impact factor: 13.501

4.  The pathology symptomatology and diagnosis of certain common disorders of the vestibular system.

Authors:  M R DIX; C S HALLPIKE
Journal:  Proc R Soc Med       Date:  1952-06

5.  An approach to the dizzy patient.

Authors:  D A Drachman; C W Hart
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

6.  Spontaneous and positional nystagmus: a reassessment of clinical significance.

Authors:  V S Dayal; L Tarantino; J Farkashidy; A Paradisgarten
Journal:  Laryngoscope       Date:  1974-11       Impact factor: 3.325

7.  Paroxysmal dyseguilibrium in the migraine syndrome of childhood.

Authors:  P Watson; J C Steele
Journal:  Arch Otolaryngol       Date:  1974-03

8.  Familial periodic nystagmus, vertigo, and ataxia.

Authors:  J C White
Journal:  Arch Neurol       Date:  1969-03

9.  Positional vertigo.

Authors:  M S Harrison; C Ozsahinoglu
Journal:  Arch Otolaryngol       Date:  1975-11

10.  [Migraine and the vestibular apparatus (author's transl)].

Authors:  M R Dürsteler
Journal:  J Neurol       Date:  1975-10-24       Impact factor: 4.849

View more
  24 in total

1.  Temporal lobe phenomena during the aura phase of migraine attacks.

Authors:  R C Peatfield
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-04       Impact factor: 10.154

Review 2.  Migraine-associated vertigo: diagnosis and treatment.

Authors:  Yoon-Hee Cha
Journal:  Semin Neurol       Date:  2010-03-29       Impact factor: 3.420

3.  Recurrent vertigo: cochlear-vestibular interaction.

Authors:  R Slater
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

4.  Benign recurrent vertigo.

Authors: 
Journal:  Br Med J       Date:  1979-09-29

Review 5.  Vestibular Migraine.

Authors:  Gülden Akdal
Journal:  Noro Psikiyatr Ars       Date:  2013-08-01       Impact factor: 1.339

6.  Association of benign recurrent vertigo and migraine in 208 patients.

Authors:  Y-H Cha; H Lee; L S Santell; R W Baloh
Journal:  Cephalalgia       Date:  2009-01-16       Impact factor: 6.292

7.  Benign paroxysmal vertigo of childhood: A review of the literature.

Authors:  Glenna Batson
Journal:  Paediatr Child Health       Date:  2004-01       Impact factor: 2.253

8.  [Clinical symptoms and classification of migraine.].

Authors:  H P Schlake
Journal:  Schmerz       Date:  1989-12       Impact factor: 1.107

9.  Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial.

Authors:  Anjali Lepcha; Sophia Amalanathan; Ann Mary Augustine; Amit Kumar Tyagi; Achamma Balraj
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-29       Impact factor: 2.503

Review 10.  Migraine-related vertigo: diagnosis and treatment.

Authors:  Scott D Z Eggers
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.